Government Contracts

  • August 17, 2007

    Auditors May Cite Ruling In Qui Tam Suit Against Shell

    Two government auditors will be able to cite a recent appeals court ruling to fight Shell Exploration & Production Co.'s contention that their claims involve public information that cannot be the basis of a qui tam action.

  • August 16, 2007

    IBM, PWC Settle Govt. Kickback Allegations

    IBM Corp. and PriceWaterhouseCoopers agreed on Thursday to pay the U.S. government around $5.3 million to settle allegations that the companies provided kickbacks to government agencies for technology contracts.

  • August 15, 2007

    ConocoPhillips Settles With DOJ For $105M

    A ConocoPhillips Co. subsidiary on Wednesday agreed to pay $105 million to settle the Department of Justice's claims that it “systematically” underpaid natural gas royalties it owed the federal government and Indian tribes.

  • July 30, 2007

    Caremark Repels Whistleblower Charges

    An appeals court panel has affirmed the dismissal of a whistleblower suit that accused pharmacy benefits manager Caremark Rx Inc. of violating the False Claims Act.

  • July 27, 2007

    Judge Orders Mediation In Drug Pricing Suit

    In a bid to bring some closure to a massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications, a federal judge has ordered certain parties in the case to resolve their differences through mediation.

  • July 25, 2007

    States Bury Hatchet With TAP Over Drug Pricing

    In a boost for TAP Pharmaceutical Products Inc., the states of Montana and Nevada have asked a federal judge to sign off on a settlement that would toss the company from a massive antitrust class action alleging that a spate of drug makers defrauded consumers by artificially inflating the prices of various prescription medications.

  • July 25, 2007

    Maximus Settles Medicaid Claim Probe

    Government services provider Maximus Inc. has agreed to pay $30.5 million to settle a criminal investigation into the Medicaid claiming work it did for the District of Columbia.

  • July 20, 2007

    Abbott Gets Third-Party Subpoenas Quashed

    Abbott Laboratories Inc., which stands accused of publishing inflated average wholesale prices for its drugs, won a victory Thursday when a judge acceded to its request to quash subpoenas that the federal government had served on former Abbott customers.

  • July 18, 2007

    Abbott Bids To Toss New Government Claims

    Abbott Laboratories, one of a slew of pharmaceutical makers involved in a massive antitrust class action alleging the companies defrauded consumers by artificially inflating the prices for various prescription drugs, has moved to dismiss fresh claims brought by government authorities.

  • July 18, 2007

    Ex-King Pharmaceutical Employee Loses Bid For Fees

    An appeals court has blocked a former King Pharmaceuticals Inc. employee from seeking additional attorneys’ fees for his efforts in bringing a wide-scale whistleblower suit against the Bristol, Tenn.-based brand-name drug maker.

  • July 17, 2007

    Special Master OKs $70M Glaxo Settlement

    The $70 million proposed settlement with GlaxoSmithKline plc in an antitrust class action that alleged it defrauded consumers by artificially inflating the prices of various prescription drugs should be approved, the case's special settlement master concluded Monday.

  • July 17, 2007

    DOJ Gets Behind Whistleblower Suit Against Fresenius

    The U.S. Department of Justice has intervened in a whistleblower suit against dialysis care provider Fresenius Medical Care Holdings Inc., accusing the company of defrauding Medicare for six years.

  • July 5, 2007

    Affiliated Computer Settles Claims Of Inflated Charges

    Affiliated Computer Services Inc. has reached an agreement to pay the U.S. more than $2.6 million to resolve allegations that it submitted inflated payment claims on several government contracts from 2002 to 2005.

  • June 29, 2007

    Bank To Pay $16M Over Destroyed Tax Returns

    Mellon Bank N.A. will pay more than $16 million to settle claims that its harried workers deleted more than 70,000 tax returns and checks in 2001 that the bank was supposed to process for the Internal Revenue Service.

  • June 29, 2007

    Dey Buries Hatchet With States In Drug Pricing Suit

    The states of Montana and Nevada have reached a settlement with Dey Inc., one of a slew of pharmaceutical companies involved in a massive antitrust class action alleging that the companies defrauded consumers by artificially inflating the prices of various prescription drugs.

  • June 27, 2007

    Relators Fight Pacific Lumber's Bid To Halt Suits

    The plaintiffs in two qui tam suits accusing Pacific Lumber Co. of fraud in connection with a $390 million deal with California and the U.S. asked the court to deny the debtors' bid to halt the suits, warning that the bankrupt logging company is playing fast and loose with facts and the law.

  • June 27, 2007

    DOJ Sues Fiber Maker For Faulty Body Armor

    A Japanese fiber maker has been hit with a lawsuit by the U.S. Department of Justice accusing the company of knowingly selling a defective fiber used in bullet-proof vests that weakened when exposed to florescent lights, heat and humidity.

  • June 26, 2007

    Pacific Lumber Tries To Block Fraud Suit

    Bankrupt timber company Pacific Lumber Co. tried on Monday to block a qui tam suit that accused the company of defrauding the state of California for over $300 million in an agreement meant to protect the environment.

  • June 21, 2007

    Judge Finds Drug Makers Liable For Inflating Costs

    A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.

  • June 20, 2007

    Plaintiffs Win More Time To Seal Glaxo Deal

    The plaintiffs in an antitrust class action alleging that a slew of pharmaceutical companies defrauded consumers by artificially inflating the prices of various prescription drugs have received more time to finalize a settlement with GlaxoSmithKline plc.